fluconazole and Carcinoma, Pancreatic Ductal

fluconazole has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bastiaens, PI; Chandra, A; Hahn, SA; Hoffmann, M; Ismail, S; Papke, B; Triola, G; Vartak, N; Waldmann, H; Wittinghofer, A; Zimmermann, G1

Other Studies

1 other study(ies) available for fluconazole and Carcinoma, Pancreatic Ductal

ArticleYear
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
    Nature, 2013, May-30, Volume: 497, Issue:7451

    Topics: Adenocarcinoma; Animals; Benzimidazoles; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 6; Dogs; Humans; Hydrogen Bonding; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Conformation; Neoplasm Transplantation; Oncogene Protein p21(ras); Protein Binding; Signal Transduction

2013